MediPharm Labs Corp. LABS MEDIF announced Friday that its subsidiary, MediPharm Labs Inc., received organic certification from Pro-Cert Organic Systems Ltd.
Pro-Cert is among North America’s leading certifiers of organic products and is accredited by IOAS, according to MediPharm.
The certification is a powerful validation of MediPharm Labs’ operations and GMP-compliant facility, the cannabis company said.
The certification will allow the company to manufacture organic extracts and oils in large amounts that could be further used as a quality ingredient in extracts, edibles, oil products and topicals targeting both medical and adult-use markets, according to MediPharm.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
“With the increasing demand for high quality, differentiated products, MediPharm Labs has again expanded its capabilities to enable our customers, and other non-cannabis CPG brands, to introduce innovative and premium, higher-margin derivative products in additional categories to the Canadian cannabis market,” MediPharm CEO Pat McCutcheon said in a statement.
“We are proud to receive this certification, which further adds third-party validation of our quality management system and integrity in the supply chain. We maintain our commitment to environmental sustainability as we continue to focus on delivering diversified product offerings to enhance the medical- and adult-use consumer experience.”
MediPharm over-the-counter shares were trading 2.23% higher at $3.69 at the time of publication Friday.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.